AXSM
AXSM
US05464T1043
Axsome Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 638.496.000 385.693.000
65.5%
Cost of Revenue 47.478.000 33.303.000
42.6%
Gross Profit 591.018.000 352.390.000
67.7%
760.253.000 604.828.000
25.7%
Operating Income -169.235.000 -252.438.000
33.0%
Pretax Income -183.704.000 -287.131.000
36.0%
Net Income Common Stockholders -183.174.000 -287.216.000
36.2%
-- --
--
-- --
--
ende